| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |